Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of AGM

19th May 2026 12:24

RNS Number : 9450E
EKF Diagnostics Holdings PLC
19 May 2026
 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that at its Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

 

For

Against

Withheld

Resolution

Votes

%

Votes

%

Votes

1

312,253,138

99.99%

1,264

0.01%

1,898,738

2

313,692,073

99.98%

57,692

0.02%

403,375

3

310,167,438

99.83%

522,512

0.17%

3,463,190

4

260,764,981

98.51%

3,945,880

1.49%

49,442,279

5

313,692,073

99.98%

57,692

0.02%

403,375

6

313,692,073

99.98%

57,692

0.02%

403,375

7

309,356,290

98.60%

4,394,675

1.40%

402,175

8

313,740,420

99.99%

10,545

0.01%

402,175

9

312,195,470

99.51%

1,524,460

0.49%

433,210

10*

310,059,158

98.83%

3,658,772

1.17%

435,210

11*

258,929,660

82.54%

54,788,270

17.46%

435,210

12*

253,090,453

82.77%

52,698,677

17.23%

8,364,010

13

174,808,673

95.16%

8,887,971

4.84%

3,406,496

 

*denotes a Special Resolution

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Julian Baines, Executive Chair / Gavin Jones, Chief Executive Officer

 via Walbrook PR

Singer Capital Markets (Nominated Adviser & Broker)

Tel: +44 (0)20 7496 3000

Phil Davies / Patrick Weaver

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings 

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

 

EKF is an AIM-listed global diagnostics business focussed on:

 

●

Point-of-Care analysers in the key areas of Hematology and Diabetes 

●

Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFDFFUEMSEEI

Related Shares:

Ekf Diagnostics
FTSE 100 Latest
Value10,351.40
Change20.85